Overview

A Phase 2 Study Investigating the Effect of EDP1815 in the Treatment of Mild to Moderate Plaque Psoriasis

Status:
Active, not recruiting
Trial end date:
2021-12-06
Target enrollment:
Participant gender:
Summary
This Phase 2 study has been designed to investigate the clinical safety and efficacy of EDP1815 and to identify an optimal dose in subjects with mild to moderate psoriasis.
Phase:
Phase 2
Details
Lead Sponsor:
Evelo Biosciences, Inc.